FdaApplication
ANDA 072219
Identifiers
- fda_app_no: ANDA072219
Properties
| Property | Value |
|---|---|
| applicant_name | AUROLIFE PHARMA LLC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | 3.75MG | CAPSULE;ORAL |
1 product